IsoFlux test showed 10 or more circulating tumor cells in four of nine samples, versus 0 with CellSearch.
New data suggest a prognosis role for the neutrophil to lymphocyte ratio.
Older adults react differently to treatment, oncology group notes.
Almost 1 in 3 not told cancer treatment might affect future fertility.
No improvement in quality of life, even for patients with good baseline performance status.
But research reveals association with pancreatic and prostate cancer.
Bladder cancer patients with and without a history of pelvic irradiation have similar recurrence-free and cancer-specific survival rates.
Even 70% of smokers support the concept of raising the legal smoking age.
No matter how much pharmacologic therapy advances, patient behavior will remain a significant factor in the outcomes achieved.
Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.
Researchers found similar post-surgical outcomes between bladder cancer patients having primary and salvage radical cystectomy.
A prolonged hospital stay and discharge to a nursing facility were among the risks.
During a median of 6.5 years of follow-up, none of the 9 cases of bladder cancer diagnosed among 925 patients was muscle invasive.
NBI was superior at detecting early bladder tumors and carcinoma in situ, compared with WLI cystoscopy.
80% of lung cancer deaths linked to smoking, researchers say.
Researchers found no association between diabetes and urinary bladder cancer risk and mortality.
Two-thirds of patients feel that tumor profiling could improve their treatment; many will pay out of pocket.
Less than half of primary care providers refer patients with any degree of hematuria for urological evaluation.
The test displayed an overall high sensitivity for detecting bladder tumors.
Men at high-risk of bladder cancer were the most likely to be referred to urologists.
Researchers find rates lower than those observed in most clinical trials.
Screened patients were more likely to die from other smoking-related malignancies.
Levels of CEA and CA 19-9 were significantly higher in patients with tumor recurrence and/or progression.
Greater effects were seen in women with UTI, according to researchers.
Patients who experienced recurrence had a higher ratio than those who did not.
Use of the medications was associated with a significant 39% decreased risk of tumor recurrence after surgery.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.
Research raises concern about the simultaneous use of chemotherapy and fish oil.
For every 5 kg/m2 increase in BMI, the risk of bladder cancer rose 4.2%.
- Erectile Function Worsens In Most Men After Prostate Biopsy
- Transperineal Prostate Biopsy Better for PCa Risk Statification
- Androgen Deprivation for Localized Prostate Cancer Ups Cardiac Risks
- Upping Shock Wave Frequency Improves Ureteral Stone Clearance
- High-Grade Prostate Cancer Linked to Low Testosterone
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)